Semiannual Report — FY2026 H1
What KNC Laboratories Co.,Ltd. reported for the period from 2026-04-01 to 2027-03-31.
Filed 2026-11-13View the original on EDINET
How much it says
43Thin
What moved here
7named for the first time
Its own wording
14terms
Which filing this is
29/ 29newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the interim accounting period, revenue increased year on year, and operating profit, ordinary profit and interim net profit all improved from the year-earlier period. In addition, funds, consisting of cash and cash equivalents, increased due to investment expenditures including the acquisition of property, plant and equipment, the acquisition of treasury shares and dividend payments.
Komori's summary of this document, not the document's own words.43Thin
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 37 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
73
Detailed
45
Typical
49
Typical
75
Very detailed
12
Almost nothing
0
Almost nothing
50
Typical
100
Very detailed
0
Almost nothing
0
Almost nothing
50
Typical
R&D spend72百万円Money spent making new things.
Cash left over9億円Cash from the business, less what went into equipment.
Spent on equipment2億円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.